Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-12

Clinical Trial Update: Resuscitative Endocrinology:Single-dose Clinical Uses for Estrogen-Traumatic Brain Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on resuscitative endocrinology using a single-dose estrogen for traumatic brain injury; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estrogen (single-dose resuscitative endocrinology approach) (Estrogen)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Traumatic Brain Injury | Phase 2 | Status: COMPLETED | Results posted: 2019-11-12